Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer
Noninvasive mutation-based and fragmentation-based cfDNA approaches can identify response to therapy in pancreatic cancer.
Related Articles
Deep learning–guided design of dynamic proteins
Deep learning has advanced the design of static protein structures, but the controlled conformational changes that are hallmarks of natural signaling proteins have remained inaccessible…
Crippling tropical diseases threaten to surge after U.S. funding cuts
Closing of programs that fought neglected diseases imperils drug donation and distribution efforts in 26 countries
Cross-regulation between the nervous system and type 2 immunity
The nervous and type 2 immune systems regulate each other via cytokines and neurotransmitters, suggesting previously unidentified therapeutic avenues.
Trump’s science adviser defends funding cuts as a chance to ‘revitalize’ U.S. science
Michael Kratsios says DEI has led to a loss of public trust in universities
Admixture’s impact on Brazilian population evolution and health
Brazil, the largest Latin American country, is underrepresented in genomic research despite boasting the world’s largest recently admixed population. In this study, we generated 2723…
Top FDA official admits she refused the Covid-19 vaccine while pregnant
A senior regulator’s admission reveals uncomfortable truths about silence, ethics and trust inside the FDA.
Trump administration bars Harvard from enrolling international students
The Trump administration has barred Harvard from allowing international students to enroll at the university.
He lost his mother, sisters, and brother to cancer. It was in their genes. – The Boston Globe
Cancer took just about everyone in journalist Larry Ingrassia’s family, except him. His book unpacks his family’s multi-generational cancer mystery.
ASCO: Roche, Jazz’s Zepzelca small cell lung cancer win leaves room for improvement
Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | Roche’s plan to bolster Tecentriq’s position…
Head of Harvard hospital’s morgue pleads guilty to selling human
The manager of Harvard Medical School’s morgue has pleaded guilty to selling human remains.